Time to disease-modifying antirheumatic drug treatment in rheumatoid arthritis and its predictors: A national, multicenter, retrospective cohort Academic Article uri icon

Overview

MeSH Major

  • Antirheumatic Agents
  • Arthritis, Rheumatoid
  • Disease Management

abstract

  • Fewer than 50% of patients with RA are treated with DMARD within 6 months from symptom onset. Time to referral to rheumatology represents the greatest component delay to treatment. Concomitant musculoskeletal condition was the most prominent predictor of delayed initiation of DMARD. Implications of these and other findings warrant further investigation.

publication date

  • November 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.3899/jrheum.120100

PubMed ID

  • 22896027

Additional Document Info

start page

  • 2088

end page

  • 97

volume

  • 39

number

  • 11